E-LIB Suche - Ergebnisse für: Fosså, A.

1

The feasibility of a multidimensional intervention in lymph..:

Bøhn, SKH ; Oldervoll, LM ; Reinertsen, KV...
Supportive Care in Cancer. 32 (2023) 1 - p. , 2023

Link: https://doi.org/10.1007/..

2

BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANC..:

Borchmann, P. ; Moccia, A. A. ; Greil, R....
Hematological Oncology. 41 (2023) S2 - p. 881-882 , 2023

Link: https://doi.org/10.1002/..

3

HTA165 Unmet Medical Need in Norwegian Clinical Practice an..:

Westermann, L. ; Fosså, A. ; Ohna, A.
Value in Health. 26 (2023) 12 - p. S350 , 2023

Link: https://doi.org/10.1016/..

4

Overall survival and causes of death in elderly patients wi..:

Lia, K. ; Jørgensen, R. R. K. ; Wold, B. L....
Hematological Oncology. 41 (2023) S2 - p. 370-371 , 2023

Link: https://doi.org/10.1002/..

5

A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PR..:

Davies, A. J. ; Zucca, E. ; Ceriani, L....
Hematological Oncology. 41 (2023) S2 - p. 48-50 , 2023

Link: https://doi.org/10.1002/..

6

WAVELINE‐004: OPEN‐LABEL, PHASE 2 STUDY OF ZILOVERTAMAB VED..:

Fosså, A. ; Ozcan, M. ; Song, Y....
Hematological Oncology. 41 (2023) S2 - p. 208-209 , 2023

Link: https://doi.org/10.1002/..

7

Toxicities at one year follow‐up in patients with advanced ..:

Ferdinandus, J. ; Moccia, A. A. ; Greil, R....
Hematological Oncology. 41 (2023) S2 - p. 363-364 , 2023

Link: https://doi.org/10.1002/..

8

S203: ABSCOPAL EFFECT OF RADIOTHERAPY AND NIVOLUMAB IN RELA..:

Bröckelmann, P. ; Bühnen, I. ; Zijlstra, J....
HemaSphere. 6 (2022) - p. 104-105 , 2022

Link: https://doi.org/10.1097/..

9

IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PR..:

Martelli, M. ; Zucca, E. ; Botto, B....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

10

OUTCOMES OF TREATMENT FOR OBESE PATIENTS WITH ADVANCED HODG..:

Preston, A. ; Kirkwood, A. ; Federico, M....
Hematological Oncology. 35 (2017) S2 - p. 172-172 , 2017

Link: https://doi.org/10.1002/..

11

RESPONSE‐ADJUSTED THERAPY FOR ADVANCED HODGKIN LYMPHOMA (RA..:

Trotman, J. ; Fosså, A. ; Federico, M....
Hematological Oncology. 35 (2017) S2 - p. 65-67 , 2017

Link: https://doi.org/10.1002/..

12

Printing nano TiO2 on large-sized building materials: Techn..:

Raimondo, M. ; Guarini, G. ; Zanelli, C....
Ceramics International. 38 (2012) 6 - p. 4685-4693 , 2012

Link: https://doi.org/10.1016/..

13

Response to "Vardenafil-Associated QTc Changes: Not Merely ..:

Fossa, A A ; Zhou, M
Clinical Pharmacology & Therapeutics. 91 (2012) 4 - p. 580-581 , 2012

Link: https://doi.org/10.1038/..

14

The Use of Beat-to-Beat Electrocardiogram Analysis to Disti..:

Fossa, A A ; Langdon, G ; Couderc, J-P...
Clinical Pharmacology & Therapeutics. 90 (2011) 3 - p. 449-454 , 2011

Link: https://doi.org/10.1038/..

15

9226 Chronic fatigue in Hodgkin lymphoma survivors – does i..:

Kiserud, C.E. ; Loge, J.H. ; Cvancarova, M....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 567-568 , 2009

Link: https://doi.org/10.1016/..